Volume 22, Issue 4, Pages e5 (October 2017)

Slides:



Advertisements
Similar presentations
Viral and Cellular Genomes Activate Distinct DNA Damage Responses
Advertisements

Volume 12, Issue 4, Pages (July 2015)
Volume 12, Issue 1, Pages (July 2012)
Volume 8, Issue 1, Pages (July 2014)
Volume 15, Issue 1, Pages (January 2014)
Volume 12, Issue 4, Pages (October 2012)
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Volume 6, Issue 5, Pages (November 2009)
Volume 14, Issue 3, Pages (September 2013)
Volume 21, Issue 11, Pages (December 2017)
Volume 11, Issue 6, Pages (June 2012)
Volume 10, Issue 6, Pages (December 2011)
Fig. 3 BX795 blocks the synthesis of HSV-1 virions.
Volume 21, Issue 5, Pages e7 (May 2017)
Volume 13, Issue 6, Pages (June 2013)
Volume 20, Issue 7, Pages (August 2017)
Luisa De Sordi, Varun Khanna, Laurent Debarbieux  Cell Host & Microbe 
HIV-1 Vpu Mediates HLA-C Downregulation
Volume 20, Issue 5, Pages (November 2016)
Volume 15, Issue 4, Pages (April 2014)
Volume 6, Issue 4, Pages (October 2009)
Volume 22, Issue 3, Pages e5 (September 2017)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 65, Issue 1, Pages (January 2017)
Volume 18, Issue 4, Pages (October 2015)
Volume 15, Issue 1, Pages (January 2014)
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Volume 22, Issue 3, Pages e5 (September 2017)
Volume 28, Issue 17, Pages e4 (September 2018)
Volume 20, Issue 4, Pages (October 2016)
Volume 22, Issue 3, Pages e3 (September 2017)
A Serpin Takes a Bite out of the Flu
Volume 2, Issue 6, Pages (December 2007)
Volume 20, Issue 5, Pages (November 2016)
Volume 22, Issue 1, Pages e7 (July 2017)
Volume 21, Issue 6, Pages (November 2017)
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
Volume 9, Issue 5, Pages (November 2017)
Volume 10, Issue 3, Pages (September 2011)
High-Throughput Fitness Profiling of Zika Virus E Protein Reveals Different Roles for Glycosylation during Infection of Mammalian and Mosquito Cells 
Volume 23, Issue 5, Pages (May 2018)
Volume 22, Issue 12, Pages (March 2018)
Volume 11, Issue 3, Pages (March 2012)
Volume 16, Issue 3, Pages (September 2014)
Volume 18, Issue 6, Pages (December 2015)
Zika Virus Infects Human Placental Macrophages
Volume 16, Issue 3, Pages (September 2014)
Hayun Lee, Yi Zhou, David W. Taylor, Dipali G. Sashital  Molecular Cell 
DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes
Volume 5, Issue 6, Pages (December 2013)
Vaccinia Virus F11 Promotes Viral Spread by Acting as a PDZ-Containing Scaffolding Protein to Bind Myosin-9A and Inhibit RhoA Signaling  Yutaka Handa,
Volume 17, Issue 4, Pages (October 2009)
Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells  Daphna Nachmani, Noam Stern-Ginossar,
John G. Purdy, Thomas Shenk, Joshua D. Rabinowitz  Cell Reports 
NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry
Sangeet Lal, Corey Raffel  Molecular Therapy - Oncolytics 
Volume 8, Issue 2, Pages (August 2010)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 20, Issue 10, Pages (September 2017)
Short Telomeres in ESCs Lead to Unstable Differentiation
Alphaherpesvirus Infection Disrupts Mitochondrial Transport in Neurons
Volume 9, Issue 2, Pages (February 2011)
Global Analysis of Palmitoylated Proteins in Toxoplasma gondii
Volume 16, Issue 2, Pages (February 2015)
Molecular Therapy - Oncolytics
Complement C4 Prevents Viral Infection through Capsid Inactivation
Volume 15, Issue 4, Pages (April 2014)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Volume 17, Issue 5, Pages (October 2016)
Volume 20, Issue 2, Pages (August 2016)
Presentation transcript:

Volume 22, Issue 4, Pages 460-470.e5 (October 2017) Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread  H.-Heinrich Hoffmann, William M. Schneider, Vincent A. Blomen, Margaret A. Scull, Alain Hovnanian, Thijn R. Brummelkamp, Charles M. Rice  Cell Host & Microbe  Volume 22, Issue 4, Pages 460-470.e5 (October 2017) DOI: 10.1016/j.chom.2017.09.002 Copyright © 2017 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2017 22, 460-470. e5DOI: (10. 1016/j. chom. 2017 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Fishtail Plot of Hits Identified in an RSV Screen (A) Outline of a genetic haploid screen. (B) Fishtail plots of the unselected control set and the RSV-selected set. Significant hits that were identified in the RSV screen are labeled by name and shown in both unselected and RSV-selected sets to highlight enrichment. Distinct gene trap insertions were mapped and counted taking into account their orientation relative to the affected genes. Per gene, the percentage of sense orientation gene trap insertions (y axis) and the total number of insertions in a particular gene (x axis) are plotted. Hits are colored to indicate their involvement in different pathways: blue, heparan sulfate biosynthesis; green, vesicular trafficking; red, Golgi calcium transporters; yellow, miscellaneous. See also Table S1. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Impaired Spread of Paramyxoviruses in SPCA1 KO Cells (A–D) Hap1 cells, CRISPR-generated WT and KO clones of SPCA1 (indicated as 1-1 derived by sgRNA#1, and 2-1, 2-2, and 2–3 derived by sgRNA#2), and SPCA1-reconstituted clones infected with (A) RSV-GFP at an MOI of 1 and (C) hPIV-3-GFP at an MOI of 4 harvested at 24 hpi. Hap1 cells, CRISPR-generated Hap1 clones, and SPCA1-reconstituted clones infected with (B) RSV-GFP at an MOI of 0.1 and (D) hPIV-3-GFP at an MOI of 0.01 harvested at 72 hpi and 48 hpi, respectively. Harvested cells were analyzed by flow cytometry and plotted as a percentage of GFP-positive cells. Data represent the mean and SD of three independent experiments. Bars are colored differently to indicate: parental WT in black; CRISPR WT clones in dark blue and green; CRISPR KO clones in light blue and green. (E) Hap1 cells and CRISPR-generated Hap1 clones infected with MeV-GFP at an MOI of 0.1 and fixed for microscopy at 36 hpi (original magnification 10×). See also Figures S1, S4, and S5. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 Hap1 Cells Reconstituted with Different SPCA1 Isoforms and Point Mutations CRISPR-generated WT and KO clones of SPCA1 were reconstituted with (A and C) SPCA1 isoforms 1A–1F and (B and D) isoform 1D bearing Hailey-Hailey disease-derived point mutations (G309C and D742Y) important in Ca2+-ion binding. Hap1 cells, unreconstituted, and reconstituted clones were infected with (A and B) RSV at an MOI of 0.1 and (C and D) hPIV-3-GFP at an MOI of 0.01. Cells, harvested at 72 hpi (A and B) and at 48 hpi (C and D), were analyzed by flow cytometry and plotted as a percentage of GFP-positive cells. See also Figures S1 and S2. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 4 Paramyxoviruses Produced in SPCA1 KO Cells Are Less Infectious (A–E) Hap1 cells infected with RSV-GFP at an MOI of 1 (A and B) and with hPIV-3-GFP at an MOI of 4 (C and D). The supernatants were harvested at 24 hpi and viral genome copies determined by qRT-PCR (A and C) and infectious particles by plaque assay (B) and TCID50 (D). (E) Hap1 cells were infected with hPIV-3-GFP at an MOI of 0.01. Cells were cultured in low serum conditions (0.1% fetal bovine serum) and supplemented as indicated with TPCK-trypsin (1 μg/mL). Data represent the mean and SD of three independent experiments. Bars are colored differently to indicate: parental WT in black; CRISPR WT clones in dark blue and brown; CRISPR KO clones in light blue and yellow. (F and G) Western blot analysis of Hap1 cells, CRISPR-generated Hap1 clones, and SPCA1-reconstituted clones for (F) SPCA1 and (G) furin. (H) Infection of Hap1 cells, CRISPR-generated Hap1 clones, and SPCA1-reconstituted clones with hPIV-3-GFP at an MOI of 2. Viral particles released into supernatants were harvested at 24 hpi and probed by western blot for the viral fusion protein F in its uncleaved F0 and cleaved F1 conformation. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 5 A Passaged hPIV-3 Isolate in SPCA1 KO Cells and Primary HAE Cell Cultures (A) The passaged hPIV-3-GFP isolate (P5) bears a mutation (D104G, indicated in red) within the furin cleavage site of the fusion protein F. The sequence in italics represents the minimal furin consensus sequence with the arrow indicating the cleavage site. The micrographs display infections of BHK-21 cells with both WT and P5 virus at an MOI of 1 at 24 hpi, indicating altered fusion properties. (B) Hap1 cells and SPCA1 KO clones were infected with both WT and passaged hPIV-3-GFP viruses at an MOI of 0.0001, harvested at 72 hpi, analyzed by flow cytometry, and plotted as a percentage of GFP-positive cells. (C) Primary human airway epithelial (HAE) cell cultures were infected with both WT and passaged hPIV-3-GFP viruses at an MOI of 0.1. Cultures were washed daily with PBS to harvest the released virus, which was subsequently titered by TCID50 assay. Data represent the mean and SD of three independent experiments. Statistical analysis was performed with a two-tailed Student’s t test with significance shown as ∗p ≤ 0.05. See also Figure S3. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 6 Decreased Levels of SPCA1 Impair Viral Spread and Production of Infectious Particles (A–C) (A) Hap1 cells and (B and C) primary HAE cell cultures were treated with a control Morpholino or a Morpholino targeting ATP2C1 at a concentration of (A) 5 μM and (B and C) 20 μM. The experiments are outlined schematically above graphs indicating treatment start relative to infection: (A) pre-treatment and post-treatment; (B) pre-treatment; and (C) post-treatment. Infections were performed with hPIV-3-GFP viruses at an MOI of (A) 0.01 and (B and C) 0.1. (A) Cells were harvested at 48 hpi, analyzed by flow cytometry, and plotted as a percentage of GFP-positive cells. Data represent the mean and SD of three independent experiments. (B and C) The cultures were washed daily with PBS to harvest the released virus, which was subsequently titered by TCID50 assay. Data represent the mean and SD of three independent experiments. (D and E) Primary fibroblasts derived from healthy control individuals (C1, C2, C3, and C4) and HHD patients (H1, H2, H3, and H4) were infected with hPIV-3-GFP at an MOI of 4 in the presence or absence of TPCK-trypsin. Cells and supernatants were harvested at 24 hpi. (D) Cells were analyzed by flow cytometry and the average of control fibroblasts (WT) and HHD fibroblasts (HHD) plotted as a percentage of GFP-positive cells. (E) Supernatants were titered by TCID50 assay and the average of control fibroblasts (WT) and HHD fibroblasts (HHD) plotted as indicated. Data represent the mean and SD of three independent experiments of four biological replicates. Statistical analysis was performed with a two-tailed Student’s t test with significance shown as ∗p ≤ 0.05, ∗∗p ≤ 0.005, and ∗∗∗p ≤ 0.0005. See also Figure S6. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 7 Impaired Spread of Flaviviruses in SPCA1 KO Cells Hap1 cells, CRISPR-generated Hap1 clones, and SPCA1-reconstituted clones infected with (A) YFV-venus at an MOI of 0.01, (B) DENV-GFP at an MOI of 0.1, (C) WNV-GFP at an MOI of 10, and (D) ZIKV at an MOI of 0.25. Cells were harvested at (A and D) 48 hpi and (B and C) 72 hpi, analyzed by flow cytometry, and plotted as a percentage of GFP-positive cells. Data represent the mean and SD of three independent experiments. Bars are colored differently to indicate: parental WT in black; CRISPR WT clones in dark blue and green; CRISPR KO clones in light blue and green. See also Figures S3, S4, and S7. Cell Host & Microbe 2017 22, 460-470.e5DOI: (10.1016/j.chom.2017.09.002) Copyright © 2017 Elsevier Inc. Terms and Conditions